According to our new research study on “PCR for respiratory infection diagnostics market” Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Product Type, Infection Type, End User,” the market is expected to reach US$ 8279.32 million by 2028 from US$ 4,146.02 million in 2021; it is estimated to grow at a CAGR of 10.4% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to the factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth.

Polymerase chain reaction (PCR) is used for accurate point of care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. In addition, PCR is widely preferred in inpatient and outpatient settings that help enhance the growth of the market in recent years.

Request sample of this research report at: https://www.theinsightpartners.com/sample/TIPRE00023326/

Key findings from the report

• The PCR for respiratory infection diagnostics market, by type, is segmented into real time PCR (qPCR), multiplex PCR, traditional PCR, digital PCR, reverse-transcriptase (RT-PCR), and others. The real-time PCR (qPCR) segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
  
• Based on product type, the PCR for respiratory infection diagnostics market is segmented into reagents and kits, instruments, and others. The reagents and kits segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR of in the market during the forecast period.
• Based on infection type, the PCR for respiratory infection diagnostics market is segmented into bacterial infection, viral infection, and fungal and other pathogens. In 2021, viral infections segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.
• Based on end user, the PCR for respiratory infection diagnostics market is segmented into hospitals, physician clinics, clinical laboratories, academic and research institutions, biotech and pharma companies, and others. In 2020, clinical laboratories segment held the largest share of the market and is estimated to register the highest CAGR of in the market during the forecast period.

The growth of the PCR for respiratory infection diagnostics market is attributed to the factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth.

PCR testing is the gold standard for detecting respiratory infectious diseases, including SARS-CoV-2. Also, the growing developments in PCR are not limited to the COVID-19 testing. The continuous technological developments have allowed researchers to develop advanced PCR techniques at a reduced cost and limit their complexities. It is expected that PCR testing will enhance its capabilities for molecular diagnostics and strengthen its role in the future with the ongoing developments of technologies such as microfluidics and next-generation sequencing. In addition, PCR testing is significantly used in institutions such as nursing homes, chronic care facilities, and hospitals, for identifying influenza virus infection that causes respiratory outbreaks.

The report segments the pcr for respiratory infection diagnostics market as follows:

By Type

• Real-Time PCR (qPCR)
• Multiplex PCR
• Traditional PCR
• Digital PCR
• Reverse-Transcriptase (RT-PCR)
• Others

By Product Type

• Reagents and Kits
• Instruments
• Others

By Infection Type

• Bacterial Infections
  • Bordetella
  • Streptococcus Pneumoniae
  • Staphylococcus Aureus
  • Haemophilus Influenzae
  • Moraxella Catarrhalis
  • Mycoplasma Pneumoniae
  • Chlamydophila Pneumoniae
  • Legionella
  • Others
• Viral Infections
  • Rhinoviruses
  • Influenza Virus
  • Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
  • Respiratory Syncytial Virus (RSV)
  • Adenovirus
  • Enterovirus
  • Parainfluenza
  • Human Metapneumovirus (hMPV)
  • Others
• Fungal and Other Pathogens

By End User

• Hospitals
• Physician Clinics
• Clinical Laboratories
• Academic and Research Institutions
• Biotech and Pharma Companies

Place an Order Now: https://www.theinsightpartners.com/buy/TIPRE00023326/

Tags: PCR For Respiratory Infection Diagnostic Market, PCR For Respiratory Infection Diagnostic Market Research, PCR For Respiratory Infection Diagnostic Market Insight, PCR For Respiratory Infection Diagnostic Market Trends, PCR For Respiratory Infection Diagnostic Market Forecast, PCR For Respiratory Infection Diagnostic Market Share

See Campaign: https://www.theinsightpartners.com/
Contact Information:
Contact Us Contact Person: Sameer Joshi Phone: +1-646-491-9876 Email Id- sales@theinsightpartners.com

Tags:
, PR-Wirein, Menafn, Research Newswire, English